A detailed history of Catalyst Capital Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 130 shares of DHR stock, worth $30,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130
Previous 130 -0.0%
Holding current value
$30,659
Previous $32,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$235.51 - $267.98 $1,884 - $2,143
-8 Reduced 5.8%
130 $32,000
Q1 2024

Apr 24, 2024

SELL
$224.58 - $256.19 $224 - $256
-1 Reduced 0.72%
138 $34,000
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $52,568 - $66,208
-284 Reduced 67.14%
139 $32,000
Q3 2023

Nov 09, 2023

SELL
$233.08 - $265.59 $524,896 - $598,108
-2,252 Reduced 84.19%
423 $104,000
Q2 2023

Aug 08, 2023

BUY
$224.99 - $256.14 $601,848 - $685,174
2,675 New
2,675 $642,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Catalyst Capital Advisors LLC Portfolio

Follow Catalyst Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.